Emerging in the field of obesity therapy, retatrutide is a unique strategy. Unlike many available medications, retatrutide functions as a double agonist, concurrently targeting both GLP-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic substance (GIP) receptors. This get more info dual stimulation encourages various advantageous effects,